Express Pharma - Page 1484 of 2248 - Express Pharma

HRV Pharma acquires Phatebo GmbH; enters European finished formulations market

Dr. Reddy’s receives marketing authorisation for generic semaglutide injection in Brazil

Lupin launches Raltegravir Tablets USP, 600 mg in the US

Pfizer drug from Medivation deal shows promise in breast cancer: Study

Keytruda improves survival for bladder cancer patients

Celgene leukaemia drug extends survival in early stage trial

Weight loss tied to lower risk of knee joint degeneration

Bristol-Myers NASH drug reduces liver fat in midstage study

Eating tree nuts may cut risk that colon cancer will return: Study

First-in-class innovation a key strategy for pharma companies in a harsh market environment: GBI Research

Haematological cancers pharma pipeline one of the strongest within oncology: GBI Research

Global immunology market to surpass $75 bn by 2022 despite patent expirations

Growth hormone deficiency market to grow steadily, surpassing $2 bn by 2026